title: The combination of selective inhibition of the cannabinoid CB1 receptor and activation of the cannabinoid CB2 receptor yields improved attenuation of motor and autonomic deficits in a mouse model of spinal cord injury.
authors.affiliation: Department of Neurosurgery, Temple University Hospital, Pittsburgh, Pennsylvania, USA.
authors.forename: Joshua E
authors.initials: JE
authors.lastname: Heller
authors.forename: Darric E
authors.initials: DE
authors.lastname: Baty
authors.forename: Ming
authors.initials: M
authors.lastname: Zhang
authors.forename: Hongbo
authors.initials: H
authors.lastname: Li
authors.forename: Martin
authors.initials: M
authors.lastname: Adler
authors.forename: Doina
authors.initials: D
authors.lastname: Ganea
authors.forename: John
authors.initials: J
authors.lastname: Gaughan
authors.forename: Christopher M
authors.initials: CM
authors.lastname: Loftus
authors.forename: Jack I
authors.initials: JI
authors.lastname: Jallo
authors.forename: Ronald F
authors.initials: RF
authors.lastname: Tuma
mesh_terms: D000818:Animals; D001341:Autonomic Nervous System / Q000187:drug effects*; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D005260:Female; D051379:Mice; D008810:Mice, Inbred C57BL; D009043:Motor Activity / Q000187:drug effects*; D010880:Piperidines / Q000008:administration & dosage*; D011720:Pyrazoles / Q000008:administration & dosage*; D043884:Receptor, Cannabinoid, CB1 / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D043885:Receptor, Cannabinoid, CB2 / Q000008:administration & dosage / Q000819:agonists*; D000077285:Rimonabant; D013119:Spinal Cord Injuries / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D001743:Urinary Bladder / Q000187:drug effects / Q000503:physiopathology
chemical_list: D010880:Piperidines; D011720:Pyrazoles; D043884:Receptor, Cannabinoid, CB1; D043885:Receptor, Cannabinoid, CB2; D000077285:Rimonabant